KOVACHKA, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 238
EU - Europa 189
AS - Asia 75
SA - Sud America 7
AF - Africa 4
OC - Oceania 1
Totale 514
Nazione #
US - Stati Uniti d'America 236
IT - Italia 76
IE - Irlanda 39
CN - Cina 30
GB - Regno Unito 19
SE - Svezia 18
HK - Hong Kong 13
IN - India 13
FR - Francia 8
UA - Ucraina 8
SG - Singapore 7
AR - Argentina 4
DE - Germania 4
JP - Giappone 4
NG - Nigeria 4
DK - Danimarca 3
ES - Italia 3
FI - Finlandia 3
NO - Norvegia 3
CL - Cile 2
MX - Messico 2
PT - Portogallo 2
QA - Qatar 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
IL - Israele 1
KR - Corea 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 514
Città #
Los Angeles 53
Dublin 39
Chandler 34
Turin 32
Ashburn 17
Fairfield 11
Nyköping 11
Central 7
Bradford 6
Singapore 6
Leeds 5
Milan 5
Princeton 5
Torino 5
Abuja 4
Crescentino 4
Hangzhou 4
Rome 4
Seattle 4
Zola Predosa 4
Barcelona 3
Bari 3
Birmingham 3
Boston 3
Chengdu 3
Copenhagen 3
Guangzhou 3
Kyiv 3
Pune 3
Skien 3
Skipton 3
Woburn 3
Beijing 2
Bloomington 2
Brooklyn 2
Buenos Aires 2
Carrara 2
Chandigarh 2
Doha 2
Dong Ket 2
Lappeenranta 2
Lisbon 2
Liupanshui 2
Medford 2
Osaka 2
Paris 2
Reston 2
Roubaix 2
Royersford 2
Suzhou 2
Talca 2
Wanchai 2
Woodbridge 2
Alessandria 1
Bangalore 1
Bangkok 1
Berlin 1
Brunflo 1
Cambridge 1
Charlotte 1
Ecatepec 1
Frankfurt am Main 1
Gattatico 1
Genoa 1
Helsinki 1
Herne 1
Herzliya 1
Hradec Králové 1
Jacksonville 1
Junín 1
Kanazawa 1
Kannur 1
Keystone Heights 1
La Louvière 1
London 1
Luzhou 1
Melbourne 1
Nanjing 1
Nice 1
Noicattaro 1
Norrköping 1
Norwalk 1
Nuremberg 1
Oklahoma City 1
Padova 1
Pisa 1
Riyadh 1
San Diego 1
Sant'Agapito 1
Santa Cruz 1
Seoul 1
Tlalpan 1
Vercelli 1
Washington 1
Weiz 1
Wilde 1
Wilmington 1
Totale 382
Nome #
New aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the hydroxytriazole scaffold 113
New inhibitors of Aldo-Keto Reductase 1C3 (AKR1C3) based on benzoisoxazole scaffold and their potential application in cancer 109
Iron metabolism at the interface between host and pathogen: From nutritional immunity to antibacterial development 85
Multiple-targeting ligands for AKR1C3 enzyme and androgen receptor to target prostate cancer 46
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 38
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 32
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein 31
HYDROXYLATED HETEROCYCLES AS BIOISOSTERES OF THE CARBOXYLIC FUNCTION: DESIGN OF NEW AKR1C3 INHIBITORS ACTIVE IN PROSTATE CANCER 28
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) 22
A community effort in SARS-CoV-2 drug discovery 15
NEW AKR1C3 INHIBITORS WITH BENZOISOXAZOLE CORE: DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITY TO TARGET PROSTATE CANCER 9
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer 5
Totale 533
Categoria #
all - tutte 2.499
article - articoli 0
book - libri 0
conference - conferenze 1.343
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 2 4 3
2020/202129 0 4 4 0 4 2 2 4 1 2 0 6
2021/202263 0 0 1 1 3 1 1 2 1 12 25 16
2022/2023208 14 13 7 23 15 63 18 4 14 10 4 23
2023/2024224 26 16 19 12 23 19 53 20 1 13 22 0
Totale 533